Ten biomarkers were consistently reported as being differentially abundant between endometrial cancer cases and controls in multiple independent studies and hence may be putative diagnostic biomarkers: levels of extracellular vesicles [18,24,32,34,35,38], LGALS3BP [19,32], miR-15a-5p [21,23] and miR-21–3p [23,27] were elevated, while miR-26a-5p [21,27], miR-130a-3p [23,27], miR-139 [23,27], miR-219a-5p [23,27], miR-222–3p [23,27] and miR-885 [23,27] were decreased in endometrial cancer cases versus controls. The gene discussed is LGALS3BP; the disease is endometrial cancer.